Streetbeat News

Products Services

AI

C3.ai Inc reported a Q1 revenue of $87.2 million, beating estimates, and a loss of 5 cents per share, also better than expected. Despite positive earnings, the stock fell 17% after-hours. The company highlighted strong demand for its AI solutions and significant growth in its partner network.

Portfolio Pulse from Chris Katje

September 04, 2024 | 8:29 pm

SHPH

Shuttle Pharma has opened enrollment for a Phase 2 clinical trial of Ropidoxuridine for glioblastoma at two sites. The company received FDA Orphan Drug Designation for the drug and regained Nasdaq compliance after filing delayed financial reports.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 8:29 pm

RLGT

Radiant Logistics has acquired Foundation Logistics & Services to enhance its capabilities in the oil and gas industry. The financial terms of the acquisition were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 8:29 pm

LLY

QGEN

QIAGEN has entered a collaboration with Eli Lilly to develop the QIAstat-Dx in-vitro diagnostic for detecting APOE genotypes, which are significant in Alzheimer's disease diagnosis. This will be the first commercially available IVD for APOE genotyping.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 8:29 pm

SFWL

Shengfeng Development is committed to expanding its logistics network and innovative solutions to serve a wider range of industries and customers.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 8:28 pm

MAX

MediaAlpha, Inc. (NYSE:MAX) and Insurify, Inc. have extended their partnership with a new multi-year agreement. This collaboration connects auto and home insurance carriers with Insurify's high-intent shoppers through MediaAlpha's platform.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 8:25 pm

ACMR

ACM Research, Inc. (NASDAQ:ACMR) has received purchase orders for four wafer-level packaging tools, with two orders from a U.S.-based customer and two from a U.S.-based R&D center. This development highlights ACM's growing presence in the semiconductor industry.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 8:24 pm

SNSE

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) will present preclinical data on its cancer therapeutic SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference in September 2024.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 8:19 pm

PSTX

Poseida Therapeutics presented a case study at the SOHO meeting, demonstrating the reactivation of their CAR-T therapy, P-BCMA-101, in a patient with relapsed multiple myeloma. This highlights the potential of their stem cell memory T cells (TSCM) in achieving a stringent complete response over three years after initial treatment.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 8:17 pm

TRVI

Trevi Therapeutics will present data from its Phase 2a CANAL trial at the ERS Congress 2024, focusing on the effects of nalbuphine ER on chronic cough in IPF patients.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 8:15 pm